ASKER — Asker Healthcare AB Cashflow Statement
0.000.00%
- SEK29.92bn
- SEK34.88bn
- SEK33.57bn
Annual cashflow statement for Asker Healthcare AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 598 | 708 | 579 | 966 | 1,009 |
| Non-Cash Items | 137 | 430 | 666 | 720 | 839 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -353 | -162 | -193 | -459 | -520 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 764 | 1,952 | 2,104 | 2,454 | 2,656 |
| Capital Expenditures | -124 | -123 | -151 | -348 | -590 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -719 | -1,737 | -632 | -1,109 | -2,316 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -1,686 | -3,720 | -1,566 | -2,914 | -5,812 |
| Financing Cash Flow Items | -4 | 404 | 59 | 8 | 9 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,238 | 1,144 | -166 | 610 | 4,050 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 161 | -283 | 181 | 99 | 394 |